Novo Nordisk Stock Falls After Ozempic Fails to Slow Alzheimer's

Shares in Novo Nordisk, the Danish maker of Ozempic and Wegovy, tumbled after studies showed the active ingredient in its hit ...

Novo Nordisk’s weight-loss-drug trial provides rare good news in a rocky year

Novo Nordisk, whose shares have stumbled this year, on Tuesday announced a positive trial result for a weight-loss drug in ...
Houston Public Media

5 things to know about the new obesity pills that are on the way

Instead of struggling with weekly injections, patients may soon be able to swallow a daily pill to lose weight. Both the ...

Forbes Daily: Google’s AI Winning Streak Continues Amid Stunning Rebound

Today’s Forbes Daily newsletter covers Amazon’s latest AI investment, Novo Nordisk’s tough Ozempic test, SoftBank stumbles, ...
Stocktwits on MSN

Novo Nordisk’s Experimental GLP-1 Drug Shows Weight Loss, Blood Sugar Levels Reduction In Study

Novo Nordisk on Tuesday said that a mid-stage trial evaluating Amycretin in people with type 2 diabetes yielded positive ...

Novo Says Next-Generation Diabetes Shot Led to 14.5% Weight Loss

Novo Nordisk A/S said a next-generation diabetes shot lowered patients’ blood sugar and helped them lose weight in a study that may be a positive sign for the embattled drugmaker’s future portfolio.